[1] Shen L, Siliciano R F. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection [J]. Journal of Allergy and Clinical Immunol,
2008, 122(1): 22-28.
[2] Perelson A S, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy [J]. Nature, 1997, 387(6629): 188-191.
[3] Haase A T, Henry K, Zupancic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue [J]. Science, 1996, 274(5289): 985-989.
[4] Hamed K A, Winters M A, Holodniy M. et al. Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy [J]. Journal of Infectious Diseases, 1993, 167(4): 798-802.
[5] Vernazza P L, Eron J J, CohenMS, et al. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men [J]. AIDS, 1994, 8(9): 1325-1329.
[6] Levy J A. HIV and the pathogenesis of AIDS [M]. 3rd ed. Washington: ASM Press, 2007.
[7] Barker C F, Billingham R E. Immunologically privileged sites [J]. Advances in Immunology, 1978, 25: 1-54.
[8] Callaway D S, Perelson A S. HIV-1 infection and low steady state viral loads [J]. Bulletin of Mathematical Biology, 2002, 64(1): 29-64.
[9] van den Driessche P, Watmough J. Reproduction numbers and sub-threshold endemic equilibrium for compartmental models of disease transmission [J]. Mathematical Biosciences, 2002, 180(1/2): 29-48.
[10] Blower S M, Gershengorn H B, Grant R M. A tale of two futures: HIV and antiretroviral therapy in San Francisco [J]. Science, 2000, 287(5453): 650-654.
[11] Lou J, Lou Y J, Wu J H. Threshold virus dynamics with impulsive antiretroviral drug effects[J]. Journal of Mathematical Biology, 2012, 65(4): 623-652.
[12] Perelson A S, Essvnger P, Cao Y, et al. Decay characteristics of HIV-infected compartments during combination therapy [J]. Nature, 1997, 387(6629): 188-191.